Joost Berkers

Publications (2)1.83 Total impact

• Source

  Available from: Dirk Jan Maria Karine De Ridder

  Article: Single incision mini-sling versus a transobutaror sling: a comparative study on MiniArc and Monarc slings.

  Dirk De Ridder, Joost Berkers, Jan Deprest, Jasper Verguts, Dieter Ost, David Hamid, Frank Van der Aa
  [show abstract] [hide abstract]
  ABSTRACT: A retrospective, dual-center, cohort study on the single incision MiniArc sling and the transobturator Monarc sling in the treatment of stress urinary incontinence is presented. We hypothesized that both systems would perform equally well. One hundred thirty-one (MiniArc n = 75, Monarc n = 56) consecutive patients were evaluated. Evaluation was performed by cough stress test (CST), daily pad use, IIQ-7, UDI-6, and a 0-5 visual analog scale for quality of life. The 1-year data are presented. Six weeks after surgery, 91% of the patients in both populations had a negative CST. At 1 year, 85% of the MiniArc group and 89% of the Monarc group (p = 0.60) maintained a negative CST. QoL, symptom scores, and number of pads improved significantly and were comparable in both groups. Complication rates were similar. These results suggest that MiniArc sling and Monarc sling are equally effective in the treatment of stress incontinence at 1 year follow-up.
  International Urogynecology Journal 03/2010; 21(7):773-8. · 1.83 Impact Factor
• Article: Glycaemic control and perioperative organ protection.

  Joost Berkers, Jan Gunst, Ilse Vanhorebeek, Greet Van den Berghe
  [show abstract] [hide abstract]
  ABSTRACT: The concept of stress hyperglycaemia as an adaptive, beneficial response in critical illness has recently been challenged. Two large prospective randomized controlled trials in the Leuven University Hospital surgical and medical ICUs demonstrated that maintenance of normoglycaemia with intensive insulin therapy substantially prevents morbidity and reduces mortality. Strict normoglycaemia is required to gain most clinical benefit. With this therapy the risk of hypoglycaemia increased, but without inducing obvious clinical sequellae. Other studies have been used to advocate against implementation of intensive insulin therapy by showing lack of benefit or questioning safety. However, these studies are inconclusive on this subject, due to problems of not reaching normal glucose levels clearly separated from the standard glycaemic group or lack of statistical power. Clearly, future studies should be adequately powered and comply with the study protocol in order to confirm the survival and other clinical benefits of intensive insulin therapy.
  Baillière&#x27 s Best Practice and Research in Clinical Anaesthesiology 04/2008; 22(1):135-49.